Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute progranulocytic leukemia.

B L Powell1

  • 1Section on Hematology/Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. bpowell@wfubmc.edu

Current Opinion in Oncology
|January 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No evidence for microsatellite instability in acute myeloid leukemia.

Leukemia·2017
Same author

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.

Leukemia·2017
Same author

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

Leukemia·2016
Same author

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Leukemia·2016
Same author

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).

Leukemia·2016
Same author

Vascular ring presenting as dysphagia in an adult woman: a case report.

Annals of the Royal College of Surgeons of England·2016
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Acute progranulocytic leukemia (APL) treatment has significantly improved with all-trans-retinoic acid (ATRA) and arsenic trioxide, achieving high response rates. Further research is needed to optimize ATRA chemotherapy schedules and manage APL complications.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Acute progranulocytic leukemia (APL) presents distinct biological and clinical characteristics.
  • Advances in understanding APL have led to substantial therapeutic improvements.

Purpose of the Study:

  • To summarize the current state of APL therapy.
  • To identify areas for future research in APL management.

Main Methods:

  • Review of current therapeutic strategies for APL.
  • Analysis of treatment outcomes with ATRA and arsenic trioxide.

Main Results:

  • Current APL therapy with ATRA and anthracyclines achieves >=85% complete response and >=70% long-term disease-free survival.
  • Arsenic trioxide is effective for relapsed APL induction therapy.

Related Experiment Videos

Conclusions:

  • Optimal ATRA plus chemotherapy schedules require definition.
  • The role of arsenic trioxide, molecular monitoring for minimal residual disease, and management of APL complications need further investigation.